Log In
Print this Print this

AAVLP (HPV16/31L2)

  Manage Alerts
Collapse Summary General Information
Company Medigene AG
DescriptionAdeno-associated virus-like particles (AAVLPs) presenting HPV minor capsid protein L2 peptides from HPV types 16 and 31
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine: Viral vaccine
Latest Stage of DevelopmentPreclinical
Standard IndicationHuman papillomavirus (HPV)
Indication DetailsPrevent HPV infection
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today